Skip to content
GenoLensGenoLens

TRA2B

Chr 3q27.2

transformer 2 beta homolog

Aliases:
Htra2-beta, PPP1R156
MANE:
ENST00000453386.7

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Early onset or syndromic epilepsy

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Severe microcephaly

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • syndromic complex neurodevelopmental disorder

    0.37
  • preeclampsia

    0.31
  • Blindness

    0.27
  • schizophrenia

    0.26
  • Respiratory insufficiency

    0.21
  • neurodevelopmental disorder

    0.19
  • hereditary disease

    0.18
  • type 2 diabetes mellitus

    0.15
  • diabetic eye disease

    0.13
  • diabetic retinopathy

    0.13

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Transformer-2 protein homolog beta

Sequence-specific RNA-binding protein which participates in the control of pre-mRNA splicing. Can either activate or suppress exon inclusion. Acts additively with RBMX to promote exon 7 inclusion of the survival motor neuron SMN2. Activates the splicing of MAPT/Tau exon 10. Alters pre-mRNA splicing patterns by antagonizing the effects of splicing regulators, like RBMX. Binds to the AG-rich SE2 domain in the SMN exon 7 RNA. Binds to pre-mRNA

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.